Morphine kinetics after diamorphine infusion in premature neonates
- PMID: 1888639
- PMCID: PMC1368489
- DOI: 10.1111/j.1365-2125.1991.tb05609.x
Morphine kinetics after diamorphine infusion in premature neonates
Abstract
1. The pharmacokinetics of morphine were studied in 26 newborn premature neonates (26-38 weeks gestational age) who were given a loading dose of 50 micrograms kg-1 of diamorphine followed by an intravenous infusion of 15 micrograms kg-1 h-1 of diamorphine. Plasma concentrations of morphine were measured during the infusion at steady-state and for 24 h after the cessation of the diamorphine infusion. 2. The mean steady-state plasma morphine concentration (+/- s.d.) for a diamorphine infusion rate of 15 micrograms kg-1 h-1 was 62.5 +/- 22.8 ng ml-1. 3. Morphine clearance was 3.6 +/- 0.9 ml min-1 kg-1, the elimination half-life was 8.9 +/- 3.3 h and the volume of distribution was 2.7 +/- 1.01 kg-1. 4. Morphine elimination kinetics were described by a mono-exponential function. 5. There was a direct relationship between the gestational age of the patients and the clearance (r2 = 0.31, P = 0.003) and half-life (r2 = 0.35, P = 0.01) of morphine, but no relationship was found between gestational age and volume of distribution. 6. The results suggest that the currently used dosing regimen of diamorphine achieves a safe and effective morphine concentration in the premature newborn but that the loading dose could be modified to achieve a more rapid onset of analgesia.
Similar articles
-
Morphine, morphine-6-glucuronide and morphine-3-glucuronide pharmacokinetics in newborn infants receiving diamorphine infusions.Br J Clin Pharmacol. 1996 Jun;41(6):531-7. doi: 10.1046/j.1365-2125.1996.03539.x. Br J Clin Pharmacol. 1996. PMID: 8799518 Free PMC article. Clinical Trial.
-
Diamorphine infusion in the preterm neonate.Arch Dis Child. 1991 Oct;66(10 Spec No):1155-7. doi: 10.1136/adc.66.10_spec_no.1155. Arch Dis Child. 1991. PMID: 1750767 Free PMC article.
-
Pharmacokinetics of morphine infusion in premature neonates.Arch Dis Child. 1993 Jul;69(1 Spec No):55-8. doi: 10.1136/adc.69.1_spec_no.55. Arch Dis Child. 1993. PMID: 8346956 Free PMC article.
-
Diamorphine pharmacokinetics and conversion factor estimates for intranasal diamorphine in paediatric breakthrough pain:systematic review.BMJ Support Palliat Care. 2024 Jan 8;13(e3):e485-e493. doi: 10.1136/bmjspcare-2021-003461. BMJ Support Palliat Care. 2024. PMID: 35184039
-
Recommended use of morphine in neonates, infants and children based on a literature review: Part 1--Pharmacokinetics.Paediatr Anaesth. 1997;7(1):5-11. doi: 10.1046/j.1460-9592.1997.d01-30.x. Paediatr Anaesth. 1997. PMID: 9041568 Review.
Cited by
-
Evaluation of a morphine maturation model for the prediction of morphine clearance in children: how accurate is the predictive performance of the model?Br J Clin Pharmacol. 2011 Jan;71(1):88-94. doi: 10.1111/j.1365-2125.2010.03802.x. Br J Clin Pharmacol. 2011. PMID: 21143504 Free PMC article.
-
An in vitro study of diamorphine permeation through premature human neonatal skin.Pharm Res. 1993 Apr;10(4):583-7. doi: 10.1023/a:1018958305002. Pharm Res. 1993. PMID: 8483842
-
Clinical pharmacokinetics of sedatives in neonates.Clin Pharmacokinet. 1996 Dec;31(6):423-43. doi: 10.2165/00003088-199631060-00003. Clin Pharmacokinet. 1996. PMID: 8968656 Review.
-
Prediction of glucuronidated drug clearance in pediatrics (≤5 years): An allometric approach.Eur J Drug Metab Pharmacokinet. 2015 Mar;40(1):53-9. doi: 10.1007/s13318-014-0178-9. Epub 2014 Feb 12. Eur J Drug Metab Pharmacokinet. 2015. PMID: 24519316
-
Morphine and morphine-6-glucuronide in the plasma and cerebrospinal fluid of children.Br J Clin Pharmacol. 1999 Jul;48(1):37-42. doi: 10.1046/j.1365-2125.1999.00948.x. Br J Clin Pharmacol. 1999. PMID: 10383558 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous